Evaluation of the therapeutic potential of exclusive antagonists of extrasynaptic nmda receptors for treatment of opioid use disorders
Ended Project Grant Awarded Last action
- Award ID
- R43DA050393
- Recipient
-
Neurano Bioscience LLC UEI JCNBY88DXRG5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $349,999
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Originally
- Place of performance
- La Jolla, CA 92093, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $349,999 |
Quick answers
Who received award R43DA050393?
R43DA050393 was awarded to Neurano Bioscience LLC by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2019.
How much is award R43DA050393 worth?
$349,999 has been obligated on R43DA050393.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award